Ziopharm Oncology Doses First DIPG Patient in Phase 1/2 Trial of Controlled IL-12 for the Treatment of Pediatric Brain Tumors
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - Category: Cancer & Oncology Source Type: clinical trials
More News: Brain | Brain Cancers | Brain Tumor | Cancer & Oncology | Clinical Trials | Neurology | Pediatrics